Durham, NC 的 骨髓纖維化 臨床試驗
12 項針對 骨髓纖維化 的研究正在 Durham（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
招募中1/2 期
- Duke Cancer Institute, Durham
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
招募中3 期
- Duke Blood Cancer Center, Durham
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
招募中1 期
- University of North Carolina At Chapel Hill, Chapel Hill · 距離 10 英里
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
招募中1 期
- Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · 距離 10 英里
Registry of Older Patients With Cancer
招募中觀察性研究
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 距離 10 英里
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
招募中1 期
- University of North Carolina, Chapel Hill · 距離 10 英里
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
招募中3 期
- DUHS Duke Blood Cancer Center ( Site 6005), Durham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
招募中2 期
- University of North Carolina, Chapel Hill · 距離 10 英里
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
招募中2 期
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Chapel Hill · 距離 10 英里
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
招募中觀察性研究
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 距離 10 英里
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
招募中3 期
- Duke University Medical Center, Durham
其他城市的 骨髓纖維化 試驗
- Houston, TX19 項研究
- New York City, NY18 項研究
- Boston, MA12 項研究
- Columbus, OH11 項研究
- Seattle, WA11 項研究
- Salt Lake City, UT10 項研究
- Miami, FL10 項研究
- Atlanta, GA9 項研究
- Baldwin Park, CA9 項研究
- Nashville, TN9 項研究
- Tampa, FL9 項研究
- Cleveland, OH9 項研究
Durham 的其他研究
- 乳癌64 項研究
- 癌症（所有類型）58 項研究
- 非小細胞肺癌39 項研究
- 多發性骨髓瘤37 項研究
- 急性髓系白血病33 項研究
- 轉移性癌症33 項研究
- 前列腺癌32 項研究
- 肺癌32 項研究
- 大腸直腸癌28 項研究
- 卵巢癌27 項研究
- 慢性淋巴性白血病27 項研究
- 心臟衰竭26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。